← SynDRA
KHS-101
SynDRA canonical compound SYN0079909 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | TACC3 |
|---|
| Mechanism of action | neural stem cell inducer |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- PTK2B
- GAK
- LTK
- INSRR
- INSR
- IGF1R
- MAPK1
- TNK1
- TNK2
- PTK2
- CLK1
- RPS6KA1
- PKN2
- RET
- RIOK3
- ROS1
- AURKB
- TAOK1
- RPS6KA2
- SMUG1
- STK33
- NUAK2
- TDG
- ULK1
- ULK2
- OGG1
- MBD4
- MYO3B
- MINK1
- CHEK2
- CLK4
- FER
- FLT3
- HDAC6
- MAP2K1
- MAP2K4
- MAP2K6
- MAPK10
- MAPK3
- MAPK7
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
- ALAT2
- COMT
- CP2C9
- CP3A7
- GAMT
- GNMT
- HNMT
- KSYK
- NNMT
- PNMT
- SYK
- TP53
Cross-references
Synonyms
- RefChem:831622
- KHS101
- KHS 101
- MFCD18206916
- MLS006010727
- orb1302408
- SCHEMBL16921054
- C18H21N5S
- EX-A2746
- KHS-101?
- EBC-08752
- AKOS026677295
- NCGC00345082-01
- NCGC00345082-02
- AC-36298
- HY-10996
- KHS101, >=98% (HPLC)
- SMR004701689
- TS-09049
- CS-0002988
- T4968
- EN300-6497833
- BRD-K78978711-001-02-5
- Z2768769343
Look up KHS-101 in the interactive SynDRA portal →